These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 36428148)
21. Prognostic significance of relaxin-2 and S100A4 expression in osteosarcoma. Huang H; Zheng HY; Liu ZL; Zhang L Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2828-34. PubMed ID: 25339476 [TBL] [Abstract][Full Text] [Related]
22. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer. Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359 [TBL] [Abstract][Full Text] [Related]
23. Expression analysis, clinical significance and potential function of PLXNB2 in acute myeloid leukaemia. Guo Z; Guo D; Kong D; Bian S; Zhao L; Li Q; Lin L; Hao J; Sun L; Li Y Mol Biol Rep; 2023 Oct; 50(10):8445-8457. PubMed ID: 37632633 [TBL] [Abstract][Full Text] [Related]
24. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma. Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314 [TBL] [Abstract][Full Text] [Related]
25. Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cells. Gil-Kulik P; Dudzińska E; Radzikowska-Büchner E; Wawer J; Jojczuk M; Nogalski A; Wawer GA; Feldo M; Kocki W; Cioch M; Bogucka-Kocka A; Rahnama M; Kocki J BMC Cancer; 2020 May; 20(1):435. PubMed ID: 32423430 [TBL] [Abstract][Full Text] [Related]
26. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia. Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331 [TBL] [Abstract][Full Text] [Related]
27. Abnormal expression of EMT-related proteins, S100A4, vimentin and E-cadherin, is correlated with clinicopathological features and prognosis in HCC. Zhai X; Zhu H; Wang W; Zhang S; Zhang Y; Mao G Med Oncol; 2014 Jun; 31(6):970. PubMed ID: 24781336 [TBL] [Abstract][Full Text] [Related]
28. Overexpression of S100A4 as a biomarker of metastasis and recurrence in oral squamous cell carcinoma. Natarajan J; Hunter K; Mutalik VS; Radhakrishnan R J Appl Oral Sci; 2014; 22(5):426-33. PubMed ID: 25466476 [TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of S100A4 mRNA and protein expression in colorectal cancer. Kang YG; Jung CK; Lee A; Kang WK; Oh ST; Kang CS J Surg Oncol; 2012 Feb; 105(2):119-24. PubMed ID: 21837681 [TBL] [Abstract][Full Text] [Related]
30. Investigation of the epithelial to mesenchymal transition markers S100A4, vimentin and Snail1 in gastroesophageal junction tumors. Mirza A; Foster L; Valentine H; Welch I; West CM; Pritchard S Dis Esophagus; 2014 Jul; 27(5):485-92. PubMed ID: 23082947 [TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome. Huang HH; Chen FY; Chou WC; Hou HA; Ko BS; Lin CT; Tang JL; Li CC; Yao M; Tsay W; Hsu SC; Wu SJ; Chen CY; Huang SY; Tseng MH; Tien HF; Chen RH BMC Cancer; 2019 Jun; 19(1):617. PubMed ID: 31234830 [TBL] [Abstract][Full Text] [Related]
32. S100A4 mRNA as a prognostic marker and therapeutic target in Wilms tumor (WT). Li HJ; Chen YX; Wang Q; Zhang YG Eur Rev Med Pharmacol Sci; 2014; 18(6):817-27. PubMed ID: 24706305 [TBL] [Abstract][Full Text] [Related]
33. The implication of lncRNA expression pattern and potential function of lncRNA RP4-576H24.2 in acute myeloid leukemia. Zheng J; Song Y; Li Z; Tang A; Fei Y; He W Cancer Med; 2019 Dec; 8(17):7143-7160. PubMed ID: 31568697 [TBL] [Abstract][Full Text] [Related]
34. High expression of LOC541471, GDAP1, SOD1, and STK25 is associated with poor overall survival of patients with acute myeloid leukemia. Yu X; Chen C; Hu Y; Li K; Zhang Y; Chen Z; Nie D; Gao R; Huang Y; Zhong M; Wang C; Wang S; Zeng Y; Li Y; Zeng C Cancer Med; 2023 Apr; 12(7):9055-9067. PubMed ID: 36708053 [TBL] [Abstract][Full Text] [Related]
35. Clinical significance of dysregulation of miR-381 in pediatric acute myeloid leukemia. Zhang P; Sun D; Sun X; Li H Eur J Med Res; 2020 Sep; 25(1):42. PubMed ID: 32938467 [TBL] [Abstract][Full Text] [Related]
36. Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. Gentles AJ; Plevritis SK; Majeti R; Alizadeh AA JAMA; 2010 Dec; 304(24):2706-15. PubMed ID: 21177505 [TBL] [Abstract][Full Text] [Related]
37. PRAME expression is not associated with down-regulation of retinoic acid signaling in primary acute myeloid leukemia. Steinbach D; Pfaffendorf N; Wittig S; Gruhn B Cancer Genet Cytogenet; 2007 Aug; 177(1):51-4. PubMed ID: 17693191 [TBL] [Abstract][Full Text] [Related]
38. Prognostic value of cytoplasmic expression of S100A4 protein in endometrial carcinoma. Chong HI; Lee JH; Yoon MS; Suh DS; Kim K; Kim JY; Choi KU Oncol Rep; 2014 Jun; 31(6):2701-7. PubMed ID: 24756855 [TBL] [Abstract][Full Text] [Related]
39. Significance of S100A4 as a prognostic marker of lung squamous cell carcinoma. Tsuna M; Kageyama S; Fukuoka J; Kitano H; Doki Y; Tezuka H; Yasuda H Anticancer Res; 2009 Jul; 29(7):2547-54. PubMed ID: 19596927 [TBL] [Abstract][Full Text] [Related]
40. Downregulation of S100A4 expression by RNA interference suppresses cell growth and invasion in human colorectal cancer cells. Huang L; Xu Y; Cai G; Guan Z; Cai S Oncol Rep; 2012 Apr; 27(4):917-22. PubMed ID: 22200787 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]